Alzheimer's Disease: The Brand
  • Why Alzheimer's Disease?
  • Curating and Creating
  • Alzheimer's Disease: The Brand...the book!
Keep tabs on the journey...
UA-62070106-1

Alzheimer's Disease and the Pending Zombie Apocalypse

5/19/2016

 
My co-author and I are knee-deep in finishing a detailed (requested) book proposal for a major educational publisher. It seems to be taking forever. We are both busy and it seems other priorities keep shadowing our efforts. The topic is Alzheimer's Disease and how it morphed into a gigantic financial juggernaut.

​For example, if the annual cost of dementia was a company, by 2030 it would exceed Google, Apple, Wal-Mart, and Exxon Mobile. And it isn't selling over-priced computers (of which I own several), data, oil, or cheap sweaters--its major commodity might just be fear.  Or it would rank as the 18th largest economy  if considered as a country.
Picture
You don't need a degree in economics to appreciate the world-wide interest in the research pipeline. It is big business. If you don't think of research as business, learn a little bit about the JP Morgan Healthcare Conference where discussions of "market expansion" refer to actual people--very sick people.
Picture
My biggest beef with the history of Alzheimer's Disease begins with how we have interpreted the early history. The first patient assigned the eponymous diagnosis was 51 years of age when examined by Alois Alzheimer. He would have classified this as pre-senile dementia or what we now call early onset Alzheimer's Disease. That fact is hardly mentioned.

The historian, Jesse F. Ballenger provides a clear perspective on the drivers of the financial incentivization of Alzheimer's Research. The clear shift of Alzheimer's as a psychiatric disorder toward a somatic illness appears to be a major facilitator.
Picture
​I speak to groups and communities about Alzheimer's Disease and my personal journey with my dad. In my experience, the most value was keeping my father home as long as manageable. I also speak of what we know about prevention. The data supporting theories of metabolic derangements common to chronic diseases of aging is strong but we aren't getting the message.

Alzheimer's disease: The Brand explores not only the political and societal driver of a monotherapeutic cure but how the medical industrial complex evolved as a perfect storm. Recall the JP Morgan Healthcare Conference. Enthusiastic CEOs speak optimistically about market expansion and  their newest  pipeline entrants. They often seem unaware of the patients represented by the "growth" data points and forward thinking statements--nestled within their safe harbors.

​The trailer below, Monster in the Mind is from a soon to be released documentary. I have not had the opportunity to see the whole movie but I will bet it doesn't corroborate the scare tactics of big R&D. The zombie apocalypse is replaced with solid science, hope, and prevention strategies that make good sense.

Share stories on our Facebook group  page or over on twitter where we are starting a community...Help spread hope!

Comments are closed.
    Picture

    Bonny

    A data analyst focuses the lens on the evolution of Alzheimer's Disease as a diagnosis into a billion dollar healthcare juggernaut

    Sign up for newsletter:

    Categories

    All
    Alzheimer's Disease
    Blog
    Medical Writer
    WHCOA

    ADTB remains a labor of love. It honors my dad and his journey with Alzheimer's disease.

    ​I spend quite a bit of time traveling and researching and hope to publish an expanded discussion of many of these insights.

    If you are able to and indeed benefit from my efforts I would appreciate your donation to keep the site ad-free and relevant.

    How about enough for a coffee? Any amount is appreciated. Thank you!
    Follow our blog about the intersection of health policy, economics, and clinical medicine.
    Picture
Powered by Create your own unique website with customizable templates.